Cheek DB, Perry JWA salt-wasting syndrome in infancy. Arch Dis Child.1958;33:252-256.
2.
Petersen S., Gies J., Kappelgaard AM, et al. Pseudohypoaldosteronism: clinical, biochemical and morphological studies in a long-term follow-up. Acta Paediatr Scand.1978 ;67:255-261.
3.
Yasuda T., Noda-cho H., Nishioka T., et al. Pseudohypoaldosteronism: decreased aldosterone levels with age without significant change in urinary sodium excretion. Clin Endocrinol.1986;24:311-318.
4.
Schindler AM , Bergman GEProspective diagnosis of pseudohypoaldosteronism . Pediatrics. 1986;78:516-518.
Oberfield SE , Levine LS, Carey RM, et al. Pseudohypoaldosteronism: multiple target organ unresponsiveness to mineralocorticoid hormones. J Clin Endocrinol Metab.1979;48:228-234.
7.
Dillon MJ, Leonard JV, Buckler JM, et al. Pseudohypoaldosteronism. Arch Dis Child.1980;55:427-434.
8.
Barakar AY, Papadopoulou ZL, August GPA hyperkalemic salt-wasting syndrome in infancy. Pediatr Res.1972;6:394. Abstract.
9.
Shackleton Chl , Snodgrass GJAI. Steroid excretion by an infant with an unusual salt-losing syndrome: a gas chromatographic-mass spectrometric study. Ann Clin Biochem.1974;11:91-99.
10.
Saule H., Dorr HG, Sippell WGPseudohypoaldosteronism in a child with Down's syndrome. Long-term management of salt loss by ion exchange resin administration. Eur J Pediatr.1984;142:286-289.
11.
Rampini S., Furrer J., Keller HP, et al. Congenital pseudohypoaldosteronism: case report and review. Effects of indomethacin during sodium chloride depletion. Helv Paediatr Acta. 1978;33:153-167.
12.
Bommen M., Brook Cgd.Pseudohypoaldosteronism. Response to long-term treatment with indomethacin . Arch Dis Child.1982;57:718-720.
13.
Postel VM, Alberti Mcgm, Ricouy C., et al. Pseudohypoaldosteronism: persistence of hyperaldosteronism and evidence for renal tubular and intestinal responsiveness to endogenous aldosterone . J Clin Endocrinol Metab.1974;39:1038-1044.
14.
Scherr L., Ogden DA, Mead AW, et al. Management of hyperkalemia with a cation-exchange resin. N Engl J Med.1961;264-115-119.
15.
Fleisher DSCation exchange resin therapy for hyperkalemia in infants and children. J Pediatr.1961;58:486-492.
16.
Berlyne GM, Janabi K., Shaw ABDangers of Resonium A in the treatment of hyperkalemia in renal failure. Lancet. 1966;1:167-169.
17.
Usberti M., Pecoraro C., Tederico S., et al. Mechanism of action of indomethacin in tubular effects. Pediatrics. 1985;75:501-507.
18.
Goldszer RC , Goodley EL, Rosner MJ, et al. Hyperkalemia associated with indomethacin . Arch Intern Med.1981;141:802-804.
